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Abstract. A modular video endoscope is developed and tested to allow imaging in different modalities. This system
incorporates white light imaging (WLI), cross-polarized imaging (CPI), and vital-dye fluorescence imaging (VFI),
using interchangeable filter modules. CPI and VFI are novel endoscopic modalities that probe mucosal features
associated with Barrett’s neoplasia. CPI enhances vasculature, while VFI enhances glandular architecture. In
this pilot study, we demonstrate the integration of these modalities by imaging areas of Barrett’s metaplasia
and neoplasia in an esophagectomy specimen. We verify that those key image features are also observed during
an in vivo surveillance procedure. CPI images demonstrate improved visualization of branching blood vessels asso-
ciated with neoplasia. VFI images show glandular architecture with increased glandular effacement associated with
neoplasia. Results suggests that important pathologic features seen in CPI and VFI are not visible during standard
endoscopic white light imaging, and thus the modalities may be useful in future in vivo studies for discriminating
neoplasia from Barrett’s metaplasia. We further demonstrate that the integrated WLI/CPI/VFI endoscope is com-
patible with complementary high-resolution endomicroscopy techniques such as the high-resolution microendo-
scope, potentially enabling two-step (“red-flag” widefield plus confirmatory high-resolution imaging) protocols to
be enhanced. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work
in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.18.2.026007]
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1 Introduction
The incidence of esophageal adenocarcinoma (EAC) has dra-
matically increased over the last four decades; since 1975,
there has been a 463% increase among men and a 335% increase
among women.1 This is of particular concern because EAC is
associated with a very low five-year survival rate (12%) due pri-
marily to diagnosis at a late stage.2 When diagnosed early, the
five-year survival rate of EAC is 81%, but only a small fraction
of esophageal cancers are detected at this stage.3
Patients with Barrett’s esophagus (BE), a condition caused
by chronic acid damage to the esophagus over time, are
known to be at an increased risk of developing EAC.4,5
Because of the high likelihood of developing dysplasia and
cancer, patients with BE are recommended to undergo regular
surveillance at designated intervals.6 During the standard sur-
veillance procedure, white light examination is used to scan
the entire Barrett’s segment for visible abnormalities, such as
nodules and ulcerations. Since many neoplastic lesions can
appear flat and indistinguishable from nondysplastic mucosa
under white light imaging, random four-quadrant biopsies are
taken every 1 to 2 cm along the Barrett’s segment.6
Unfortunately, this method has been shown to miss as many
as 57% of dysplasias and cancers.7 Thus, there is an important
need for new techniques that may improve the early diagnosis of
EAC and its precursors.
In an attempt to improve image contrast and diagnostic yield, a
number of widefield endoscopic imaging modalities have been
developed. Autofluorescence imaging (AFI) is sensitive to
changes in stromal collagen fluorescence and increased epithelial
thickness;8 neoplasia is associated with loss of detected autofluor-
escence intensity. AFI has been shown to identify abnormal
lesions with 91% sensitivity.9,10 However, inflammatory lesions
can also demonstrate loss of fluorescence, and the specificity
of AFI can be as low as 43%;9 other studies have also shown
high rates of false positives associated with AFI.11
Narrowband reflectance imaging uses narrow bands of blue
and green illumination to enhance vascular content, indirectly
enhancing the appearance of the glandular pit pattern and achiev-
ing a sensitivity range of 89% to 100% and a specificity range of
76% to 98% for detecting neoplasia.12–14 Moreover, reported
specificities for detecting BE are as low as 65%.15 Though
both technologies enhance mucosal changes in different ways,
signal differences have been shown to aid clinical interpretation
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of mucosal features.10,11 However, limitations associated with
false positives reinforce the need for new imaging techniques.
Recent ex vivo studies suggest that two emerging widefield
modalities show promise in improving the early recognition of
esophageal neoplasia. In the first approach, cross-polarized im-
aging (CPI), tissue is illuminated with linearly polarized white
light, and light re-emitted from the tissue surface is collected via
a second linear polarizer, whose axis of transmission is oriented
orthogonally to that of the incident light. CPI preferentially col-
lects light scattered from subsurface tissue structures, thereby
enhancing the contrast of deeper blood vessels.16 CPI has
been shown in various organ sites to improve the identification
of epithelial neoplasia,17,18 though it has yet to be implemented
for in vivo endoscopic imaging.
In the second approach, vital-dye enhanced fluorescence im-
aging (VFI), a fluorescent dye is used to enhance tissue fluores-
cence. Proflavine hemisulfate, a fluorescent contrast agent,
stains cell nuclei, enabling observation of relevant changes in
epithelial architecture associated with neoplastic progression.
Ex vivo studies of VFI and proflavine staining in gastrointestinal
tissues have shown that the agent allows for the evaluation of
glandular architecture during widefield imaging.19
While CPI and VFI have demonstrated their utility in other
organ sites or with ex vivo specimens, evaluating their utility for
in vivo esophageal cancer screening requires the development of
an upper GI endoscope capable of acquiring images in these
modalities. Here, we describe the development and initial clini-
cal evaluation of a modular video endoscope (MVE) that incor-
porates white light imaging (WLI), CPI, and VFI modalities. We
present images acquired with the MVE from an ex vivo esopha-
geal specimen with pathologically confirmed disease, as well as
in vivo images acquired during endoscopic assessment of a
patient with Barrett’s-associated neoplasia.
2 Materials and Methods
2.1 Instrumentation
The MVE shown in Fig. 1 was designed to acquire images in
three different modalities: conventional WLI, CPI, and VFI. The
MVE consists of a modified high-definition (1280×
1024 pixels) video processor (Pentax EPK-i), a standard
upper GI video endoscope (Pentax EG-29901), and stainless
steel modules attached to the distal tip of the endoscope contain-
ing the necessary optical filters for CPI or VFI implementation.
Each module is coupled to the distal tip with a medium-sized,
commercially available endoscope cap (Barrx Medical Inc.,
Sunnyvale, California) shown in the right panel of Fig. 1.
The custom-designed filter modules maintain use of the stan-
dard features of the endoscope during CPI and VFI imaging,
including the forward water jet used for irrigation and the
air/water nozzle used to clear debris from the field of view
(FOV) of the charge coupled device (CCD). The dimensions
are shown in Fig. 2. In all three imaging modalities, the system
is designed to be used at the standard working distance of the
endoscope, ranging from 5 to 20 mm. A digital zoom feature
allows up to 3× additional magnification. The FOV depends
on both the working distance and the digital magnification;
at a typical working distance of 10 mm, the FOV ranges
from 15 to 45 mm in diameter, with a resolution of approxi-
mately 50 μm. At the minimum working distance of 5 mm,
the FOV ranges from 5 to 15 mm in diameter, with a resolution
of approximately 25 μm.
2.1.1 Cross-polarized imaging
In CPI, tissue is illuminated with linearly polarized white light,
and images are acquired through a second linear polarizer
Fig. 1 The top diagram illustrates the placement of linear polarizers in front of the illumination light guides and CCD for CPI implementation. The image
to the right of the CPI diagram shows the distal end of the endoscope tip with the CPI filter module in place. The bottom diagram illustrates the
placement of the longpass filter in front of the CCD for VFI implementation. The image to the right of the VFI diagram shows the distal end of
the endoscope tip with the VFI filter module in place. In VFI mode, the light guides emit blue light from the laser diode. The panel on the right
shows the endoscope tip (top) and module assembly (bottom) using the silicone cap.
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oriented to transmit only reflected light, with its axis of polari-
zation oriented orthogonally to that of the illumination light.
This serves both to reject specular reflection from the tissue sur-
face and to enhance the appearance of subsurface vasculature.
The top row of Fig. 1 shows the module designed to adapt the
standard endoscope for CPI imaging.
To achieve CPI, white light from the endoscope light guides
pass through linear polarizers (2.15 × 3 mm2) contained in the
cap, one in front of each end of the bifurcated light guide (indi-
cated by the stars in the CPI filter module image of Fig. 1); this is
done to accommodate the illumination channels that exist in the
Pentax video endoscope. The module holds another linear polar-
izer (4.6 × 4.8 mm2) in front of the CCD camera; the axis of this
polarizer is oriented orthogonally to that of the illumination
polarizers. These filters are fixed in the module using optically
clear epoxy (Epo-Tek, Billerica, Massachusetts). The filters are
cut from HN22 polarizing sheets (Knight Optical Ltd., UK); the
thickness of the film is 0.75 mm, and the maximum transmission
of two orthogonally oriented sheets is 0.001%. With the CPI
module in place, the surface irradiance at the center of the
FOV is approximately 3.6 mW∕cm2 at 5 mm and approximately
1.9 mW∕cm2 at 10 mm; both are typical working distances for
imaging.
2.1.2 Vital-dye fluorescence imaging
In VFI mode, tissue is illuminated with quasi-monochromatic
light designed to excite fluorescence; a long-pass filter is placed
in front of the CCD camera to reject specular reflection at the
excitation wavelength and to allow for the collection of resulting
fluorescence. The VFI module was designed specifically to
image fluorescence following topical application of the fluores-
cent antiseptic proflavine hemisulfate, which has been shown to
localize in cell nuclei. The agent has an absorption maximum at
450 nm and an emission maximum at 515 nm. The bottom row
of Fig. 1 shows the module designed to adapt the standard endo-
scope for VFI imaging.
To provide illumination during VFI, a 455-nm laser diode
(Nichia Corporation, Tokyo, Japan) was installed in the Pentax
EPK-i; light from the blue laser diode was coupled to the bifur-
cating light guide used during white light imaging, and a
mechanical control on the processor was used to switch between
the two illumination modes. A driver (Wavelength Electronics,
Bozeman, Montana) controls the input current to the laser
diode and thus allows variation of the illumination intensity.
The module holds a custom-designed long-pass filter (4.6×
4.8 mm2) passing wavelengths of more than 500 nm in front
of the CCD for the collection of proflavine fluorescence. The fil-
ters were cut from a custom-coated colored glass filter (Schott
North America, Inc., Duryea, Pennsylvania); the thickness of
the filter is 0.8 mm, and the optical density (OD) at the illumi-
nation wavelength is 3.8. The filter was designed to have out-of-
band rejection of at least OD 3 for light ranging from normal inci-
dence up to 70 deg incidence, accommodating the angular FOVof
the endoscope. The edges of the filter were coated black to min-
imize the effect of stray light on the image. The filters were
installed using a medical-grade, optically clear epoxy (#301-
2FL, Epo-tek, Billerica, Massachusetts). With the module and
the blue laser diode in place, the surface irradiance at the center
of the FOV is approximately 14.9 mW∕cm2 at 5 mm and approx-
imately 7.5 mW∕cm2 at 10 mm; both are typical working distan-
ces for imaging.
2.1.3 High-resolution microendoscopy
The MVE was designed to acquire widefield images in both CPI
and VFI modes; in addition, it was designed to be compatible
with a high-resolution microendoscope (HRME) capable of
resolving subcellular detail in areas identified as suspicious dur-
ing widefield imaging. The HRME has been previously
described20–22 and has been used during in vivo endoscopy to
visualize gastrointestinal pathology using proflavine contrast.23
In this system, the light from a 455-nm LED is coupled to a
fiber-optic bundle for tissue illumination. The fluorescence
from proflavine stained tissue is collected by the bundle
while in contact with the tissue and is delivered to a CCD cam-
era through a 550-nm bandpass filter with a cut-on wavelength
of approximately 500 nm. The field of view of the HRME is
720 μm in diameter, and the spatial resolution is 4.5 μm.
2.1.4 Image capture
Image collection is achieved through a custom designed inter-
face (Labview 2010, National Instruments, Austin, Texas). The
program displays the HD signal (1280 × 1024 pixels) via a
DVI-to-USB capture card (Epiphan Systems, Ottawa,
Ontario, Canada) and allows for the collection of both digital
video and image frames. The interface also allows the user to
adjust brightness and contrast where appropriate and to store
information such as the date and time of the procedure.
2.1.5 Instrument performance
The system resolution was determined by capturing an image of
a U.S. Air Force resolution target (Newport Corp., Irvine,
California). To assess background autofluorescence, images
were acquired in VFI mode from a 2-in. diameter nonfluorescent
frosted quartz disk (which approximates tissue reflectance) with
settings that matched or exceeded those used for proflavine
stained tissue. The measurements were used to verify the
absence of excitation light leakage and to assess the perfor-
mance of the emission filter.
Fig. 2 Front face of the module (a) and right cross-sectional profile
(b) shown with dimensions (mm). Regions are labeled to indicate
which features on the endoscope tip correspond to the cuts. Black
stars in (a) indicate extruded cuts created to accommodate illumination
channels. A cross-sectional profile (b) is obtained from the dotted line in
(a). Blue arrows indicate extruded cuts made for filters and epoxy. The
protrusion (white star) in (b) indicates the channel for the forward water
jet. The protrusion was implemented to aid in alignment of the module
and the endoscope tip.
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2.2 Pilot Study
The MVE was used to acquire images from clinically normal
and abnormal areas of the esophagus in vivo during endoscopic
surveillance and ex vivo immediately following surgical resec-
tion. Patients at Mount Sinai Medical Center were eligible to
participate in the study if they met the following criteria:
They had or previously had histologically confirmed Barrett’s
metaplasia and were undergoing either routine surveillance or
endoscopic treatment for Barrett’s metaplasia or Barrett’s-asso-
ciated dysplasia. A healthcare provider described the study to
eligible patients. Patients gave written informed consent prior
to participation. The study was reviewed and approved by
the IRBs at Mount Sinai Medical Center and Rice University.
2.2.1 Ex vivo imaging procedure
The MVE was used first to acquire images of an esophagectomy
specimen. Immediately following surgical resection, the
mucosal surface of the specimen was rinsed with saline and
imaged with a digital single-lens reflex (SLR) camera
under white light illumination. Visually abnormal and normal
sites were identified by the study pathologist based on appear-
ance; borders of these regions were marked on the white
light image.
Areas identified by the pathologist as grossly normal and
abnormal were imaged using all three widefield imaging modal-
ities; images were first acquired using WLI, then using CPI, and
then in VFI mode. The specimen was imaged ex vivo at a fixed
working distance of 5 mm to allow for optimal correlation
between image sites and subsequent pathological assessment.
Before VFI imaging, proflavine hemisulfate (0.01% w/v) was
applied to the mucosal surface of the sample using a sterile cot-
ton tip applicator. Excess proflavine was removed with dry
gauze. Finally, high-resolution images were acquired using
the HRME from clinically normal and abnormal areas.
In order to ensure the same FOV was imaged with each im-
aging modality, the distance from the edge of the specimen,
landmarks such as vessels, islands of squamous or columnar tis-
sue, and the perimeter of the squamo-columnar junction were
tracked as each widefield modality was used. To track high-res-
olution imaging, widefield images were taken of the probe in
contact with the mucosa, verifying that the images were
obtained from the same FOV. In an effort to reduce sampling
error, black or blue ink was placed at each area imaged,
fixed with acetic acid, and photographed. Since the ink spread
to approximately 2 to 4 mm in diameter, the photograph guided
the approximation of image sites on the resected specimens nec-
essary to facilitate registration between widefield imaging, high-
resolution imaging, and subsequent histopathologic evaluation.
The specimen was then fixed in formalin and submitted for
standard histopathologic analysis; vertical cross-sections were
examined to grade and verify the presence of disease. The
study pathologist, blinded to the image results, assigned diag-
noses to histologic sections of inked areas using standard his-
tologic criteria.
2.2.2 In vivo imaging procedure
The MVE was next used in vivo to acquire images during endo-
scopic surveillance using three high-definition imaging modal-
ities: WLI, CPI, and VFI. After endoscopic surveillance using
WLI, the scope was removed, the module for CPI was placed on
the distal tip, and the scope was reinserted. The scope was
removed again after CPI, the VFI module was installed, and
the scope was inserted a third time. Following the third insertion,
proflavine (5 to 10 mL) was administered via spray catheter
(Olympus America, Center Valley, Pennsylvania) on the epi-
thelial surface, and VFI images were acquired. Finally, the endo-
scopist introduced the HRME probe via the instrument channel
of the endoscope and placed the probe in gentle contact with the
tissue surface. HRME images were obtained from sites consid-
ered clinically abnormal using widefield imaging. Additional
HRME images were obtained from sites that were considered
clinically normal by widefield modalities. Widefield imaging
in all three modes and high-resolution imaging were performed
by a single endoscopist.
In order to ensure the images in all modalities were taken at
the same site, three pieces of information were recorded during
the procedure: clinical landmarks indicated by the endoscopist
(such as Barrett’s borders, islands, ulceration, or bleeding),
endoscope depth and quadrant, and time stamps during the pro-
cedure (upper right hand corner of every video). Post-procedure,
videos were evaluated frame by frame to ensure images from the
same site were extracted from each modality. All extracted
image frames associated with each image site were reviewed
by researchers (NT, ML, SA, RRK).
2.2.3 Endoscopic image criteria
The entire Barrett’s segment was scanned for apparent abnor-
malities with each image modality, using image criteria devel-
oped from previous ex vivo imaging studies.19,20 CPI images
were considered suspicious if they demonstrated increased
and abnormal vascularization, with crowding and branching
of blood vessels, or if there were areas of glandular effacement.
VFI images were considered suspicious if they demonstrated
alterations in glandular architecture or glandular effacement.
HRME images were considered abnormal if they exhibited
enlarged, crowded, and pleomorphic nuclei. Images were also
considered abnormal if they revealed overlapping glands that
were heterogeneous in size and shape with irregular luminal
spacing. Many abnormal areas also exhibited loss of overall
glandular architecture.19,20
After imaging, biopsies were obtained from areas deemed
suspicious in any of the imaging modes. Then, standard four-
quadrant biopsies were taken every 1 to 2 cm of the BE segment.
Images acquired from suspicious sites were compared to the his-
tologic evaluation of the biopsy from the same site. In addition,
biopsies of nonneoplastic regions containing Barrett’s metapla-
sia were obtained as controls.
3 Results
3.1 Instrument Performance
At the minimum working distance of 5 mm, the system can
resolve a line spacing of at least 24.8 μm (group 4, element
3). At a typical working distance of 10 mm, the system can
resolve a line spacing of at least 49.5 μm (group 3, element
3); the performance was unchanged with the incorporation of
the imaging modules. The ratio of signal from proflavine stained
tissue to frosted quartz imaged using the same settings was
always greater than 10:1.
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3.2 Pilot Study
3.2.1 Ex vivo: MVE images of esophagectomy specimen
The MVE was used to acquire images from five sites on a single
esophagectomy specimen. Histopathology results were avail-
able from all five sites; two were diagnosed as non-neoplastic
Barrett’s, two were diagnosed as adenocarcinoma, and one was
diagnosed as carditis. Figures 3 and 4 show representative
images of neoplastic and non-neoplastic tissue from this
specimen. Figure 3 compares images of BE (top row) and
adenocarcinoma (bottom row) in WLI and CPI modes. As
expected, CPI images show reduced specular reflection
(black arrows) and enhanced vascular contrast. In images of
Barrett’s metaplasia, vessels are better visualized in the
cross-polarized image when compared to the same areas in
the white light image (white boxes). In the images showing
adenocarcinoma, not only are the vessels better visualized,
but the increase in vasculature and vessel branching associated
with neoplasia is more readily apparent (white box).
Figure 4 shows images acquired from BE (top row) and
adenocarcinoma (bottom row) in WLI and VFI modes. The
VFI image of Barrett’s metaplasia allows for visualization of
regular-appearing glandular architecture (white box). The
edges of the glands are discernible, and the pattern appears con-
sistent throughout the region. The corresponding HRME image
shows nuclear staining primarily at the gland edges, indicating
polarized nuclei, which is characteristic of non-neoplastic
Barrett’s metaplasia.19,20 This feature can also be seen in the cor-
responding vertical histology cross-section, which shows
Barrett’s metaplasia.
Fig. 3 The top row shows (a) white light image and (b) cross-polarized
images of Barrett’s metaplasia. The bottom row shows (c) white light
image and (d) cross-polarized image of intramucosal carcinoma.
Black arrows show areas where specular reflection appears reduced
in the CPI image. White boxes in the CPI image indicate areas
where vessel branching is enhanced when compared with the same
areas in the WLI. Images were acquired from an ex vivo esophageal
specimen.
Fig. 4 The top row shows the (a) white light image, (b) vital-dye fluorescence image, and (c) high-resolution fluorescence image of proflavine-stained
Barrett’s metaplasia. The white box in (b) indicates a region where glandular architecture is clearly visible. The bottom row shows the (e) white light
image, (f) vital-dye fluorescence image, and (g) high-resolution fluorescence image of proflavine-stained intramucosal carcinoma. The yellow box in
(f) indicates partial glandular effacement, and white boxes indicate complete effacement. The yellow arrows in (g) indicate small, irregularly shaped
glands, and the yellow box indicates a gland with disrupted edges. The white box indicates an area of nuclear crowding. Corresponding histologic
cross-sections are shown (d) and (f). Note the ink on the surface of each histologic section, verifying that the section was taken from the imaged area.
Images were acquired from an ex vivo esophageal specimen.
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The VFI image of adenocarcinoma allows visualization of
partly effaced (yellow box) and completely effaced (white
box) glandular architecture. The gland edges are no longer
clearly discernible. The HRME image shows nuclear crowding,
small and irregularly shaped glands (yellow arrows), loss of
nuclear polarity within the glands (yellow box), and absence
of glands in some areas (white box). These features are mirrored
in the corresponding vertical histology cross-section, which
shows adenocarcinoma.
3.2.2 In vivo: MVE images obtained during endoscopy
In vivo imaging was conducted on one patient. During the endo-
scopic procedure using the MVE, three sites were imaged (using
all four modalities) and biopsied. Two sites were diagnosed as
non-neoplastic BE, and one was diagnosed as adenocarcinoma.
Figure 5 shows representative images from a site diagnosed
as BE. In Fig. 5(a), the white light image shows glandular archi-
tecture with some vascular detail. The CPI image in Fig. 5(b)
again shows enhanced vascular contrast. Indeed, both larger ves-
sels and smaller vessels that were not visible during WLI
become clear (white box). In the VFI image shown in Fig. 5(c),
glands are present throughout the examined area. Gland borders
appear wide, and there is little interruption between the border
edges. High-resolution imaging with the HRME through the
instrument channel of the endoscope in Fig. 5(d) allows for a
magnified view of the features seen in VFI. Gland border
edges appear regular (yellow boxes) and similar throughout
the FOV. Nuclei within these regions appear polarized toward
the gland edges. These features, along with intestinal-type gob-
let cells, are apparent in the corresponding vertical histology
cross-section in Fig. 5(e), showing Barrett’s metaplasia,
which is negative for dysplasia.
Figure 6 shows images from a site diagnosed as adenocarci-
noma. In Fig. 6(a), the WLI shows a flat, nonulcerated lesion
with both vascular and glandular abnormalities. In the CPI
image of the same area, shown in Fig. 6(b), the pattern of vessel
branching is easier to assess when compared with WLI (white
box). AVFI image of the same area, shown in Fig. 6(c), shows
glands that appear partly effaced in some regions (white boxes)
and completely effaced in others (yellow boxes). Proflavine
staining is heterogeneous throughout the area. The HRME
image shown in Fig. 6(d) reveals crowded glandular structures
with irregular gland borders (yellow boxes), along with nuclear
Fig. 5 In vivo images of an area of Barrett’s metaplasia in (a) white light,
(b) cross-polarized, (c) vital-dye fluorescence, and (d) high-resolution
imaging modes. The white boxes in (b) indicate areas where the appear-
ance of vessel branching is enhanced. The yellow boxes in (d) show
regular gland edges and indicate gland borders where nuclei are pri-
marily polarized toward the edge. The corresponding histopathology
cross-section is shown in (e).
Fig. 6 In vivo images of an area of adenocarcinoma in (a) white light,
(b) cross-polarized, (c) vital-dye fluorescence, and (d) high-resolution
imaging modes. The white boxes in (b) indicate areas where appear-
ance of vessel branching is enhanced when compared to (a). The
white boxes in (c) indicate partial glandular effacement, and the yellow
boxes indicate complete effacement. The yellow boxes in (d) show
irregular gland edges, and the white box indicates a border where
nuclei appear crowded. The corresponding histopathology cross-
section is shown in (e), where black boxes indicate areas of LGD,
HGD, and ACA.
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crowding both within the glands and outside of the glands (white
box). Nuclei also appear pleomorphic. The histologic section
presented in Fig. 6(e) was diagnosed as adenocarcinoma.
4 Discussion
In summary, we reported the technical development and initial
ex vivo and in vivo evaluation of a multimodal endoscopic im-
aging system capable of high-definition white light imaging,
cross-polarized reflectance imaging, and vital-dye enhanced
fluorescence imaging. We showed technical compatibility
with a previously reported high-resolution microendoscope im-
aging system, demonstrating the potential for the multimodal
endoscope to be used in conjunction with probe-based micro-
endoscopic technologies. CPI and VFI are novel endoscopic
modalities that probe important mucosal features; CPI enhances
vasculature, while VFI highlights changes in glandular architec-
ture. Additionally, HRME imaging allows higher-resolution
examination of glandular morphology, including nuclear char-
acteristics such as pleomorphism and crowding. We have dem-
onstrated the feasibility of these modalities by imaging areas of
Barrett’s metaplasia and associated neoplasia on an esophagec-
tomy specimen. We verified that the key image features of neo-
plastic and non-neoplastic tissue were also observed during an in
vivo surveillance procedure. The results suggest that key patho-
logical features seen in CPI, VFI, and HRME imaging are not
easily visible during standard endoscopic white light imaging.
Therefore, these imaging methods may be useful in future in
vivo studies for discriminating dysplasia and cancer from
Barrett’s metaplasia.
In this study, we find that CPI improves visualization of vas-
culature without significantly altering the white light appearance
of the image. A number of groups have used vascular contrast
enhancement to improve disease detection. Groner et al. used
cross-polarization to improve the visualization of microcircula-
tion.16 Roblyer et al. used CPI to probe the diffusely reflecting
light predominately coming from deep mucosal layers.18,24
Though vascular contrast enhancement can be valuable, an
inherent tradeoff of CPI is the loss of surface architecture
due to the rejection of photons reflected off the tissue surface.
Moreover, as the spatial resolution of white light imaging con-
tinues to improve through the development of higher-definition
endoscopes, we must evaluate whether CPI would add a signifi-
cant amount of information over those improvements.
Regardless, a larger study is necessary to understand whether
the tradeoff that enhances the ability to visualize deeper
blood vessels would improve overall accuracy.
VFI with proflavine contrast improves visualization of glan-
dular architecture by providing contrast to epithelial cell nuclei.
This is particularly important because glandular architecture
changes during the progression to neoplasia.25 Previous studies
using other modalities have shown that the assessment of such
features can improve Barrett’s surveillance.12 Narrowband im-
aging reveals some glandular features that have been docu-
mented and have been used to identify neoplasia with high
sensitivity12,13 but low specificity in identifying Barrett’s meta-
plasia.15 Since VFI uses a nuclear stain, it provides a more direct
assessment of glandular architecture. The added benefit of using
VFI is the potential for implementing high-resolution imaging at
the same time, thus providing the ability to monitor nuclear
changes at two different scales. For instance, the histology sec-
tion presented in Fig. 6(e) was diagnosed as adenocarcinoma,
but the histologically verified presence of both LGD and
HGD within the regions, indicated by black boxes in Fig. 6(e),
may be contributing to the overall heterogeneity in the VFI
image shown in Fig. 6(c). A situation like this may prompt
the endoscopist to use the HRME probe on a number of sites
within the area imaged by VFI to understand the differences
in proflavine signal and help determine, for example, the area
to biopsy.
The HRME allows for more detailed interrogation of glan-
dular architecture and the examination of features such as
nuclear size, shape, distribution, and crowding. Previous studies
have shown that these features can be consistently identified in
HRME images and correlate with the appearance observed in
H&E stained histologic sections.19–21 Moreover, image process-
ing algorithms have been developed for quantitative analysis of
digital HRME images; initial pilot studies show high sensitivity
and specificity for identifying neoplastic lesions,26 suggesting
the potential to use HRME imaging together with algorithm-
assisted identification of early cancers and high-grade dysplasia.
Proflavine is the principal component of acriflavine, which
has been used during in vivo fluorescence imaging in Europe
and Australia without any noted adverse effects.27 Indeed,
this investigational in vivo human study of confocal microscopy
for gastrointestinal cancers uses topical acriflavine at 0.05%
concentration, five times more than what is used for VFI and
HRME imaging. Moreover, the agent has been clinically
used as an antibacterial agent. In neonatal care, triple dye (a
combination of brilliant green, proflavine hemisulfate, and gen-
tian violet) is routinely used as a topical antibacterial agent on
the umbilical stump of newborn babies,28 with a recent review of
the practice categorizing toxicity as rare.29 In this pilot study, the
proflavine concentration is significantly lower than that of com-
mercial triple dye, 0.11% (w/v) (Kerr Triple Dye, Vista Pharm,
Birmingham, Alabama).
Though each of the presented modalities appears to improve
the visualization of relevant mucosal changes, additional studies
are needed to determine the overall in vivo effectiveness of each
modality. Indeed, larger in vivo studies are needed to assess the
sensitivity and specificity for detection of neoplasia for each
modality and whether this represents an improvement over
white light examination and standard four-quadrant biopsies.
Thus, the development of an instrument that can easily imple-
ment these modalities in vivo is particularly useful. Testing each
modality individually will help determine which imaging tech-
nique would be most useful to clinicians for in vivo surveillance;
the result would be a potential candidate for widespread clinical
testing. In the future, additional studies looking at both qualita-
tive and quantitative image features are needed to investigate
which are most relevant for endoscopic image interpretation.
The module-based imaging technique presented here allows
for the testing of new imaging modalities to determine feasibility
quickly. This modular concept can be adapted to any video
endoscope for the upper or lower gastrointestinal tract, thereby
extending its utility to the detection of additional gastrointestinal
abnormalities, such as colon and gastric cancers. Past widefield
fluorescence imaging studies using contrast agents did not take
full advantage of recent CCD advances, potentially limiting
what mucosal features could be resolved. By using a filter mod-
ule to image, we can maintain the benefits of the high-definition
CCD (1280 × 1024 pixels) while enabling the examination of
different optical markers of disease. Moreover, this dual-scale
platform can be adapted to measure other molecular targets
that have been used in the gastrointestinal tract with similar
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excitation and emission properties,30 such as 2-NBDG or other
targeted fluorescence contrast agents.31,32 Furthermore, the sig-
nal associated with these fluorescent contrast agents can be
quantified and used to aid in subjective image interpretation,26,30
thereby further increasing its potential as a surveillance tool.
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